September 17-20, 2020 Kyoto, Japan For further information please visit the following page: https://www.c-linkage.co.jp/jsawac2020/

September 10-15, 2020 Montebello, Quebec, Canada For further information please visit the following page: https://www.ciaweb.org/2020-symposium

July 5-9, 2020 Prague, Czech Republic For further information please visit the following page: https://www.ephar2020.org/

June 9-13, 2020 and June 14-18, 2020Varadero beach, Cuba.This Convention is the fusion of the 5th International Congress on Immunopharmacology (IMMUNOPHARMACOLOGY 2020) to be held in June 9-13, 2020 and the 5th International Congress on Pharmacology of Vaccines (VACCIPHARMA 2020), to be held in June

June 6-10, 2020London, UK For more information please visit: https://www.eaaci.org/eaaci-congresses/eaaci-2020

April 23-25, 2020Rome, Italy For more information, please visit: https://www.worldallergy.org/wisc2020  

Annual meeting from the French Society Immunology on Nov 10-12 2019 in Nantes, France. The French “Mast Cell & Basophil Club” will have a dedicated session during the meeting with keynote speaker Dr. Adrian Piliponsky (Seattle Children’s Research Institute). For more info, program and registration,

We are pleased to let you know that the 9th European Mast Cell and Basophil Research Network (EMBRN) meeting is scheduled to be in Uppsala, Sweden from Monday, June 17th to 19th, 2019. The meeting will be held at the Old University building in Uppsala,

Immunological Reviews just published a series of reports on mast cells, basophils and their role in health and disease (Immunological Reviews 2018; Vol 82, page 1-277). The 15 contributions of this volume were coordinated and, for the most part, developed by EMBRN members. Came out real

Prague, 25th – 27th May, 2017The meeting at the Institute of Molecular Genetics in Prague was focused on 4 major topics: (I) Plasma membrane receptors and mast cells and basophils signaling, (II) Mast cells and basophils exocytosis and mediators, (III) Mast cells and basophils diseases,